temoporfin has been researched along with Sensitivity and Specificity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hopper, C; Niziol, C; Sidhu, M | 1 |
Bezdetnaya, L; Guillemin, F; Kachatkou, D; Sasnouski, S; Zorin, V | 1 |
Barberi-Heyob, M; Guillemin, F; Merlin, JL; Rezzoug, H | 1 |
Kostron, H; Ritsch-Marte, M; Zimmermann, A | 1 |
1 trial(s) available for temoporfin and Sensitivity and Specificity
Article | Year |
---|---|
mTHPC-mediated photodynamic diagnosis of malignant brain tumors.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Feasibility Studies; Female; Glioma; Humans; Intraoperative Care; Male; Mesoporphyrins; Microscopy, Fluorescence; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Phototherapy; Radiation-Sensitizing Agents; Sensitivity and Specificity | 2001 |
3 other study(ies) available for temoporfin and Sensitivity and Specificity
Article | Year |
---|---|
The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.
Topics: Computer Simulation; Cost-Benefit Analysis; Head and Neck Neoplasms; Health Care Costs; Humans; Mesoporphyrins; Models, Econometric; Palliative Care; Photochemotherapy; Sensitivity and Specificity; Treatment Outcome; United Kingdom | 2004 |
Redistribution of Foscan from plasma proteins to model membranes.
Topics: Binding Sites; Blood Proteins; Cholesterol, HDL; Fluorescence Resonance Energy Transfer; Kinetics; Lipids; Membranes, Artificial; Mesoporphyrins; Models, Molecular; Photosensitizing Agents; Sensitivity and Specificity; Thermodynamics | 2006 |
Sensitive isocratic liquid chromatographic assay for the determination of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin in plasma and tissue with electrochemical detection.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Colonic Neoplasms; Electrochemistry; Female; Humans; Mesoporphyrins; Mice; Mice, Nude; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity | 1997 |